News

NorTech to honor 3 bioscience innovations with 2010 awards

Northeast Ohio’s technology economic development organization, NorTech, has chosen three bioscience products to receive its 2010 Innovation Awards.

CLEVELAND, Ohio — Northeast Ohio’s technology economic development organization, NorTech, has chosen three bioscience products to receive its 2010 Innovation Awards.

The annual awards recognize innovation achievements of the region’s organizations and leaders. This year, 12 winners were selected from industries including instruments, controls and electronics; advanced materials; information and communication technologies; and advanced energy, in addition to bioscience, according to a NorTech release.

“NorTech is pleased to showcase some of the most exciting innovations being developed and commercialized right here in Northeast Ohio,” said Rebecca O. Bagley, president and CEO of  NorTech, in the release. “We strongly believe that the innovations being honored this year will help advance existing technology industries and build new ones throughout our region.”

The bioscience projects to be honored Feb. 24 at LaCentre Conference and Banquet Facility in Westlake, Ohio are:

  1. Renaissance System 1000ViewRay Inc., a company that moved to Oakwood Village, Ohio from Florida in 2008, is developing radiation technology that precisely targets cancer tumors by using magnetic resonance images. Using real-time imaging to control and measure radiation dosages could reduce patient side effects and improve cure rates.
  2. SilvamistUniversity of Akron researchers led by Wiley J. Youngs have identified silver-based compounds that can treat cystic fibrosis. The researchers’ first product, Silvamist, is an inhaled drug candidate licensed to Akron University start-up Akron Research Commercialization Corp., which is commercializing the drug.
  3. Radio frequency telemetry system for implantable bio-MEMS sensors — NASA Glenn Research Center in Cleveland has patented a wireless system that powers and collects data from sensors implanted in the human body. Newly licensed to Endotronix of Peoria, Ill., the innovation eventually could help thousands of people avoid the complications of hypertension, abdominal aortic aneurysms and congestive heart failure, NASA said in a release.